Skip to content

StatSensor StatStrip Gen 2.0

by Nova Biomedical Corporation 2 variants

StatSensor StatStrip Gen 2.0 (66768) is a Class II device made by Nova Biomedical Corporation, cleared under FDA 510(k) K232075 on 23 Feb 2024 and listed in FDA GUDID since 6 May 2026 (UDI-DI 00385480667685), active as of 23 Oct 2026. 3 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

510(k) K232075

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00385480667685 UDI-DI Date6 May 2026ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Dual Track NumberK232075 Date23 Feb 2024DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K232075 decided 23 Feb 2024 Active
  • FDA GUDID UDI-DI 00385480667685 listed 6 May 2026 Listed

Recalls

3 recalls · 3 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-3128-2026 FDA Class I initiated 29 Jul 2026
    • Ongoing Z-3129-2026 FDA Class I initiated 29 Jul 2026

    A software synchronization/timing issue in the barcode scanning and patient data processing component that causes the device to intermittently retain a previously scanned barcode including patient identification (ID) barcodes and quality control (QC) solution ID barcodes when a new barcode is scanned, resulting in the prior barcode information remaining displayed on the screen for the current test. When this defect occurs and the operator accepts the incorrectly displayed patient information without recognizing the mismatch, the current patient's glucose result will be incorrectly assigned to the previous patient's medical record and transmitted to the data management system (DMS), and the current patient's medical record will not receive a result, leaving their glucose status unrecorded and their clinical management without the information needed to guide treatment decisions. The previous patient, whose medical record now contains a glucose result that does not belong to them, may receive inappropriate clinical intervention based on that erroneous result, particularly in critically ill patients, neonates, and infants who cannot communicate symptoms or self-treat. The defect also affects QC barcode scanning: if a QC scan triggers the same retention behavior, QC results may be attributed to an incorrect identifier or QC tests may fail without the user recognizing the underlying cause. This defect does not affect the analytical accuracy of glucose measurements.

    • Ongoing Z-0681-2025 FDA Class I initiated 20 Nov 2024

    A software bug within the Gen 2 StatStrip Hospital Meter firmware leads to transmission of erroneous glucose patient test results to a healthcare institution's data management system (DMS) at healthcare sites using WiFi if a user navigates to the Review Results screen while the meter is in the process of transmitting the current glucose test result to the DMS. The risk of this software defect is erroneously high or low glucose results being documented in a patient's medical record, which may lead to incorrect treatment.

Timeline

5 dated events

  1. Cleared FDA 510(k) K232075
  2. Recall initiated FDA recalls Z-0681-2025
  3. Listed FDA GUDID 00385480667685
  4. Recall initiated FDA recalls Z-3128-2026
  5. Recall initiated FDA recalls Z-3129-2026

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
StatSensor StatStrip
Generic name
Glucose monitoring system IVD, point-of-care
Model / Ref / Catalog
Gen 2.0, 66768
Primary DI / UDI-DI
00385480667685
510(k) Number
FDA product code
PZI
GMDN term
Glucose monitoring system IVD, point-of-care
Device class
Class II
Regulation number
862.1345
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code PZI (Prescription use blood glucose meter for near-patient testing).

Other devices from Nova Biomedical Corporation

See all devices from Nova Biomedical Corporation →

Properties

  • Serial number
Other properties (14, all answered No)